If the treatment plan involves non-insulin therapy, the non-insulin diabetes medications category can help organize nearby product types
Multi-biomarker combination detection system for diagnosis and classification of dry eye disease by imaging of a multi-channel metasurface
2013 Alan L Miller
View Study [4]"Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting" Levolger S, Wiemer EAC, et al., 2019 Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting
Patients with lower VD levels exhibited more pronounced microbial dysbiosis
Professor Lotte Bjerre Knudsen, Dr Thomas Kruse and Dr Jesper Lau of Novo Nordisk a leading global pharmaceutical company have played central roles in the discovery and development of the medicine, which has reshaped the treatment of type 2 diabetes and chronic weight management worldwide